Alnylam Pharmaceuticals (ALNY) Exchange Rate Effect (2009 - 2026)

Alnylam Pharmaceuticals has reported Exchange Rate Effect for 9 years, with the latest figure at -$7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Exchange Rate Effect fell 150.25% year-over-year to -$7.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.8 million (up 57.69% YoY), and the FY2025 full-year result was $34.9 million, up 329.25% from the prior year.
• Exchange Rate Effect for Q1 2026 stood at -$7.1 million, down from -$5.7 million in the prior quarter.
• The five-year high for Exchange Rate Effect was $27.5 million in Q2 2025, with the low at -$17.3 million in Q4 2024.
• Historically, Exchange Rate Effect has averaged $682000.0 across 5 years, with a median of -$927000.0 in 2025.
• Annual changes were most pronounced in 2024 — Exchange Rate Effect tumbled 2300.0% — and 2025, when it soared 981.6%.
• Alnylam Pharmaceuticals' Exchange Rate Effect stood at $1.6 million in 2022, then surged by 573.07% to $10.9 million in 2023, then slumped by 258.49% to -$17.3 million in 2024, then jumped by 66.99% to -$5.7 million in 2025, then slipped by 23.91% to -$7.1 million in 2026.
• The last three Exchange Rate Effect figures came in at -$7.1 million (Q1 2026), -$5.7 million (Q4 2025), and -$927000.0 (Q3 2025), per Business Quant data.